BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 104 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $25,241,000 | -17.7% | 3,100,864 | -18.4% | 0.02% | -26.5% |
| Q4 2018 | $30,657,000 | +4.4% | 3,798,853 | -1.3% | 0.03% | +25.9% |
| Q3 2018 | $29,376,000 | +47.7% | 3,850,003 | +10.9% | 0.03% | +42.1% |
| Q2 2018 | $19,891,000 | +19.0% | 3,471,438 | -0.9% | 0.02% | +11.8% |
| Q1 2018 | $16,717,000 | +10.5% | 3,504,595 | +13.7% | 0.02% | +13.3% |
| Q4 2017 | $15,134,000 | -6.1% | 3,082,235 | +0.2% | 0.02% | -11.8% |
| Q3 2017 | $16,121,000 | +39.3% | 3,076,461 | +47.8% | 0.02% | +41.7% |
| Q2 2017 | $11,569,000 | -25.3% | 2,080,818 | +12.8% | 0.01% | -29.4% |
| Q1 2017 | $15,495,000 | +80.6% | 1,844,636 | +36.1% | 0.02% | +70.0% |
| Q4 2016 | $8,578,000 | +44.0% | 1,355,100 | +0.3% | 0.01% | +66.7% |
| Q3 2016 | $5,959,000 | +54.7% | 1,351,330 | -0.4% | 0.01% | +50.0% |
| Q2 2016 | $3,852,000 | +0.3% | 1,356,302 | -0.1% | 0.00% | 0.0% |
| Q1 2016 | $3,842,000 | -72.4% | 1,357,604 | +0.7% | 0.00% | -71.4% |
| Q4 2015 | $13,917,000 | -7.8% | 1,348,563 | +1.8% | 0.01% | -6.7% |
| Q3 2015 | $15,100,000 | -23.2% | 1,324,549 | +0.5% | 0.02% | -16.7% |
| Q2 2015 | $19,674,000 | +123.9% | 1,317,717 | +35.4% | 0.02% | +125.0% |
| Q1 2015 | $8,787,000 | +179.5% | 973,099 | +202.7% | 0.01% | +166.7% |
| Q3 2014 | $3,144,000 | -23.2% | 321,422 | +0.1% | 0.00% | -25.0% |
| Q2 2014 | $4,092,000 | +7.9% | 320,942 | -10.5% | 0.00% | 0.0% |
| Q1 2014 | $3,794,000 | +39.7% | 358,557 | +0.3% | 0.00% | +33.3% |
| Q4 2013 | $2,716,000 | -17.1% | 357,352 | -20.6% | 0.00% | 0.0% |
| Q3 2013 | $3,276,000 | – | 450,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |